Thus, our results demonstrate that Ascl2 participated in stemness maintenance of cancer progenitor cells and that Ascl2 interference led to HT-29 cells tumor growth arrest in vitro and in vivo through suppression of the stemness of colon cancer progenitor cells present in the repertoire of HT-29 cells. The gene discussed is ASCL2; the disease is cancer.